| # | Drug | Count |
|---|---|---|
| 0 | CALCIUM | 2 |
| 1 | PREGABALIN | 2 |
| 2 | ACETAMINOPHEN | 1 |
| 3 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 |
| 4 | ALPRAZOLAM | 1 |
| 5 | AMLODIPINE | 1 |
| 6 | CYCLOPHOSPHAMIDE | 1 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 1 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 1 |
| 9 | DENOSUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GIVOSIRAN SODIUM | 1 | 0.0006 |
| 1 | GLUTAMINE | 1 | 0.0002 |
| 2 | PRAMIPEXOLE | 1 | 0.0001 |
| 3 | HYDROXYUREA | 1 | 0.0000 |
| 4 | VOXELOTOR | 1 | 0.0000 |
| 5 | VENETOCLAX | 1 | 0.0000 |
| 6 | PANTOPRAZOLE SODIUM INJECTION | 1 | 0.0000 |
| 7 | DULOXETINE HYDROCHLORIDE | 1 | 0.0000 |
| 8 | PREGABALIN | 2 | 0.0000 |
| 9 | PANTOPRAZOLE SODIUM | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Calcium [EPC] | 2 |
| 1 | Alkylating Drug [EPC] | 1 |
| 2 | Amino Acid [EPC] | 1 |
| 3 | Anti-epileptic Agent [EPC] | 1 |
| 4 | Antimetabolite [EPC] | 1 |
| 5 | Atypical Antipsychotic [EPC] | 1 |
| 6 | BCL-2 Inhibitor [EPC] | 1 |
| 7 | Benzodiazepine [EPC] | 1 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 9 | Calcium Channel Blocker [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hemoglobin S Polymerization Inhibitor [EPC] | 1 | 0.0000 |
| 1 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Calcium [EPC] | 2 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Expectorant [EPC] | 1 | 0.0000 |
| 6 | Anti-epileptic Agent [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 8 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 9 | Vitamin D [EPC] | 1 | 0.0000 |